Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1. / Pires, Carlota; Schmid, Benjamin; Petræus, Carina; Poon, Anna Fong-Yee; Nimsanor, Natakarn; Nielsen, Troels Tolstrup; Waldemar, Gunhild; Hjermind, Lena Elisabeth; Nielsen, Jørgen Erik; Hyttel, Poul; Freude, Kristine.
I: Stem Cell Research, Bind 17, Nr. 2, 09.2016, s. 285-288.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1
AU - Pires, Carlota
AU - Schmid, Benjamin
AU - Petræus, Carina
AU - Poon, Anna Fong-Yee
AU - Nimsanor, Natakarn
AU - Nielsen, Troels Tolstrup
AU - Waldemar, Gunhild
AU - Hjermind, Lena Elisabeth
AU - Nielsen, Jørgen Erik
AU - Hyttel, Poul
AU - Freude, Kristine
N1 - Copyright © 2016 Helmholtz Zentrum München. Published by Elsevier B.V. All rights reserved.
PY - 2016/9
Y1 - 2016/9
N2 - Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease causing neural cell degeneration and brain atrophy and is considered to be the most common form of dementia. We previously generated an induced pluripotent stem cell (iPSC) line from an AD patient carrying an A79V mutation in PSEN1 as an in vitro disease model. Here we generated a gene-corrected version from this hiPSC line by substituting the point mutation with the wild-type sequence. The reported A79V-GC-iPSCs line is a very useful resource in combination with the A79V-iPSC line in order to study pathological cellular phenotypes related to this particular mutation.
AB - Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease causing neural cell degeneration and brain atrophy and is considered to be the most common form of dementia. We previously generated an induced pluripotent stem cell (iPSC) line from an AD patient carrying an A79V mutation in PSEN1 as an in vitro disease model. Here we generated a gene-corrected version from this hiPSC line by substituting the point mutation with the wild-type sequence. The reported A79V-GC-iPSCs line is a very useful resource in combination with the A79V-iPSC line in order to study pathological cellular phenotypes related to this particular mutation.
U2 - 10.1016/j.scr.2016.08.002
DO - 10.1016/j.scr.2016.08.002
M3 - Journal article
C2 - 27879212
VL - 17
SP - 285
EP - 288
JO - Stem Cell Research
JF - Stem Cell Research
SN - 1873-5061
IS - 2
ER -
ID: 173288754